Tocilizumab in Extracranial Giant-Cell Arteritis and Takayasu Arteritis: A Multicentric Observational Comparative Study

Tocilizumab (TCZ) has demonstrated potential efficacy in managing large-vessel (LV) vasculitis such as giant-cell arteritis (GCA) and Takayasu arteritis (TAK). Despite the shared characteristics between the LV-GCA phenotype and TAK, there are differences between both entities that may affect therape...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Carmen Lasa-Teja, Javier Loricera, Diana Prieto-Peña, Fernando López-Gutiérrez, Pilar Bernabéu, María Mercedes Freire-González, Beatriz González-Alvarez, Roser Solans-Laqué, Mauricio Mínguez, Iván Ferraz-Amaro, Santos Castañeda, Ricardo Blanco, on behalf of the Tocilizumab in Large-Vessel Vasculitis Spanish Collaborative Group
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2025-01-01
coleção:	Sci
Assuntos:	tocilizumab Takayasu’s arteritis giant-cell arteritis large-vessel vasculitis
Acesso em linha:	https://www.mdpi.com/2413-4155/7/1/12
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!